Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer
Clinical trial NCT00875264 · COMPLETED
Trial details
- NCT number
- NCT00875264
- Sponsor
- Cephalon
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2011-06-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.